XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Restricted Shares
RSUs
Common Stock
Common Stock
Restricted Shares
Common Stock
RSUs
Additional Paid-in Capital
Additional Paid-in Capital
Restricted Shares
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2020       540,714,692            
Beginning balance at Dec. 31, 2020 $ 1,553     $ 0     $ 2,596   $ (1,043) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted stock and restricted stock units (in shares)       660,269   14,899,985        
Vesting of restricted stock and restricted stock units 0   $ 0       0      
Common stock issued upon exercise of warrants (in shares)       504,477            
Common stock issued upon exercise of warrants 6           6      
Exercise of stock options (in shares)       4,242,075            
Exercise of stock options 7           7      
Issuance of common stock in connection with the February 2021 Offering (in shares)       32,817,421            
Issuance of common stock in connection with the February 2021 Offering 857           857      
Stock-based compensation 409           409      
Net loss (414)               (414)  
Ending balance (in shares) at Jun. 30, 2021       593,838,919            
Ending balance at Jun. 30, 2021 2,418     $ 0     3,875   (1,457) 0
Beginning balance (in shares) at Mar. 31, 2021       585,691,729            
Beginning balance at Mar. 31, 2021 2,384     $ 0     3,697   (1,313) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted stock and restricted stock units (in shares)         329,042 3,163,113        
Vesting of restricted stock and restricted stock units   $ 0 0              
Common stock issued upon exercise of warrants (in shares)       504,477            
Common stock issued upon exercise of warrants 6           6      
Exercise of stock options (in shares)       4,150,558            
Exercise of stock options 7           7      
Stock-based compensation 165           165      
Net loss (144)               (144)  
Ending balance (in shares) at Jun. 30, 2021       593,838,919            
Ending balance at Jun. 30, 2021 2,418     $ 0     3,875   (1,457) 0
Beginning balance (in shares) at Dec. 31, 2021       616,026,565            
Beginning balance at Dec. 31, 2021 $ 2,248     $ 0     3,955   (1,705) (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted stock and restricted stock units (in shares)         142,129 8,543,024        
Vesting of restricted stock and restricted stock units   0 0     $ 0   $ 0    
Exercise of stock options (in shares) 2,321,000     2,321,415            
Exercise of stock options $ 3     $ 0     3      
Stock-based compensation 134           134      
Other comprehensive loss (3)                 (3)
Net loss (26)               (26)  
Ending balance (in shares) at Jun. 30, 2022       627,033,133            
Ending balance at Jun. 30, 2022 2,356     $ 0     4,092   (1,731) (5)
Beginning balance (in shares) at Mar. 31, 2022       622,918,512            
Beginning balance at Mar. 31, 2022 2,347     $ 0     4,028   (1,677) (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Vesting of restricted stock and restricted stock units (in shares)         69,211 3,619,795        
Vesting of restricted stock and restricted stock units   $ 0 $ 0              
Exercise of stock options (in shares)       425,615            
Exercise of stock options 1           1      
Stock-based compensation 63           63      
Other comprehensive loss (1)                 (1)
Net loss (54)               (54)  
Ending balance (in shares) at Jun. 30, 2022       627,033,133            
Ending balance at Jun. 30, 2022 $ 2,356     $ 0     $ 4,092   $ (1,731) $ (5)